Axio Biosolutions
PrivateLast Round
Series B
Jul 27, 2021
Total Funding Raised
$21M
Company Overview
Axio Biosolutions operates in Healthcare & Life Sciences and is based in Ahmedabad. Its latest recorded funding round was a Series B round in July 2021.
Axio Biosolutions is a medical technology company that provides biomaterials-based medical devices for pre-hospital, intra-operative, and post-operative clinical needs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Defense Tech
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axio Biosolutions Comparables
Compare Axio Biosolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CELOX Medical | 90% | |
| Cresilon | 85% | |
| Beeken Biomedical | 79% |
For institutional investors. Book with your work email.
Axio Biosolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 27, 2021 | ||||
| Series B Extension | Jan 9, 2020 | ||||
| Series B | Jan 26, 2018 | ||||
| Series A | May 25, 2016 | ||||
| Grant | Sep 11, 2013 | ||||
Seed | Dec 3, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axio Biosolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GVFL | Seed |
| Omidyar Network India | Series B, Series B Extension |
| Department of Science & Technology | Grant |
| TrueScale Capital | Series B |
| 360 ONE Asset | Series B |
| Chiratae Ventures | Series B Extension, Series A, Series B |
| Accel | Series B Extension, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Collaborated on a trauma management workshop at Motoverse 2025.
- Dec 8, 2025
Co-hosted trauma management workshop at Motoverse 2025.
For institutional investors. Book with your work email.
Axio Biosolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axio Biosolutions's valuation, stock price, and market status.
Is Axio Biosolutions a public or private company?
Axio Biosolutions is a private company.
What is the current stock price of Axio Biosolutions?
Axio Biosolutions is a private company, so its shares have no public market price. Caplight tracks Axio Biosolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axio Biosolutions worth (valuation)?
Valuation information for Axio Biosolutions is not publicly available.
Can I buy Axio Biosolutions stock?
Axio Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axio Biosolutions's last funding round?
Axio Biosolutions's most recent funding round was Series B on July 27, 2021.
Who are the main investors in Axio Biosolutions?
Key investors in Axio Biosolutions include Omidyar Network India, TrueScale Capital.
Will Axio Biosolutions IPO soon?
No public IPO plans have been announced for Axio Biosolutions.
How can I track Axio Biosolutions secondary market activity?
Caplight tracks bids, offers, and trades in Axio Biosolutions's shares on secondary markets.